A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer
Conclusions:
The improvement in LUTS in men with locally advanced or metastatic prostate cancer after 24–48 weeks suggests that triptorelin is effective in improving LUTS in this subgroup of patients.
Source: Therapeutic Advances in Urology - Category: Urology & Nephrology Authors: Gil, T., Aoun, F., Cabri, P., Maisonobe, P., van Velthoven, R. Tags: Original Research Source Type: research
More News: Algeria Health | Cancer | Cancer & Oncology | Hormones | Prostate Cancer | Study | Urology & Nephrology